Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$53,844,941
+$14,315,629 QoQ
Shares Held
212,013
+11.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.30%
of 13F equity value
Holder Rank
#424
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $143,988,175 across 14 Drug Manufacturers - General names. JNJ ranks #1 (37.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
212,013 | $53,844,941 | |
| 2 | ABBV |
AbbVie Inc.
|
162,450 | $40,878,917 | |
| 3 | MRK |
Merck & Co., Inc.
|
106,435 | $13,676,897 | |
| 4 | LLY |
ELI LILLY & Co
|
8,529 | $10,229,939 | |
| 5 | AMGN |
Amgen Inc
|
22,744 | $8,236,057 | |
| 6 | NVS |
Novartis AG
|
46,466 | $7,282,150 | |
| 7 | PFE |
Pfizer Inc
|
158,728 | $3,822,169 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
49,346 | $2,843,316 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,844,941 | 212,013 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $39,529,312 | 191,009 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $33,009,210 | 178,024 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $26,392,603 | 172,783 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $26,041,357 | 157,027 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $23,103,623 | 159,754 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $25,970,762 | 160,254 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $23,370,106 | 159,894 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $25,417,968 | 160,680 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $22,211,468 | 141,709 | Shares | Sole | 2024-03-08 | |
| 2023-09-30 | $24,675,316 | 158,429 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $25,806,057 | 155,909 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $24,270,675 | 156,585 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $27,228,124 | 154,136 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $24,232,168 | 148,336 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $25,953,736 | 146,210 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $25,551,957 | 144,174 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $24,995,037 | 146,110 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $23,789,273 | 147,302 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $24,184,984 | 146,807 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $23,592,935 | 143,553 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $22,710,719 | 144,305 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $21,226,118 | 142,572 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $19,966,647 | 141,980 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $23,078,092 | 175,994 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||